Consulting services for life sciences, pharmaceuticals, biotechnology and medical device companies in the nature of compliance program development and enhancement and transparency program support, namely, reviewing program status and performing gap analyses, drafting programs plans, program implementation support, development and improvement of policies, standard operating procedures and codes of conduct; consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionals, healthcare organizations, patients, and other customers; consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionals, healthcare organizations, patients, and other customers; consulting services in the nature of investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or code, industry code, or law or regulation; consulting services in the nature of conducting trainings for life sciences, pharmaceuticals, biotechnology, and medical device companies personnel and partners on pharmaceutical and medical device compliance program requirements, fraud and corruption laws and regulations, industry codes and best practices; transparency reporting regulatory submission management, namely, assisting others in preparing and filing regulatory submissions in the field of transparency reporting; consulting services, namely, tracking and monitoring regulatory requirements for others in the field of life sciences, pharmaceuticals, biotechnology, and medical devices for regulatory compliance; reviewing, developing, training on and assisting with the implementation and monitoring of standards, practices, procedures and policies to support regulatory compliance for companies in the fields of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services, namely, compliance program gap analysis for life sciences, pharmaceutical, biotechnology, and medical device companies; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in configuring their internal systems, applications, and healthcare practitioner and healthcare organization data to facilitate compliance and support transparency reporting; consulting services, namely, developing and providing trainings for life sciences, pharmaceutical, biotechnology, and medical device companies in the field of corporate compliance and transparency programs

Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; compliance audits in the field of life sciences, pharmaceutical, biotechnology and medical device companies regulatory compliance; consulting services in the field of life sciences, pharmaceutical, biotechnology and medical device corporate compliance program and transparency program development, implementation and support